NCT04771286View on ClinicalTrials.gov

A Study in Healthy Men to Find Out How BI 1015550 is Taken up and Handled by the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 25, 2021

Primary Completion Date

May 17, 2021

Study Completion Date

May 17, 2021

Conditions
Healthy
Interventions
DRUG

BI 1015550 (C-14)

BI 1015550 (C-14)

Trial Locations (1)

9728 NZ

PRA Health Sciences Onderzoekscentrum Martini, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY